Bristol Myers Squibb is dedicated to conscientious corporate citizenship, aiming to make a positive difference globally. They are focused on supporting efforts that help patients and their families, improve healthcare, and advance scientific understanding, while also contributing to building strong communities.
The Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Leadership Awards (Winn-CILA) are three-year career and leadership awards intended for oncology and cardiovascular graduates of the Winn CDA program. Sponsored by the Bristol Myers Squibb Foundation, the awards focus on providing clinical researchers with advanced knowledge in clinical trials, leadership skills, mentorship, and sponsorship essential for succeeding as independent researchers and leaders. The Winn-CILA has specific tracks for oncology, coordinated by the American Society of Clinical Oncology (ASCO), and cardiovascular research, implemented by the American Heart Association (AHA). Each track aims to enhance participants’ abilities to conduct diverse and successful clinical trials. The program supports salary, training-related costs, and encourages diversity in cardiovascular and cancer clinical research.